Ascensia Diabetes Care U.S., Inc.
CONTOUR® NEXT GEN Blood Glucose Monitoring System
SKU K223293UPC NBW
In Stock
—
IIFDA 510(k) Cleared (K223293)
1
Free shipping on orders over $99 · 30-day returns
Ascensia Diabetes Care U.S., Inc.
Free shipping on orders over $99 · 30-day returns
CONTOUR® NEXT GEN Blood Glucose Monitoring System is an FDA 510(k)-cleared medical device (K223293) manufactured by Ascensia Diabetes Care U.S., Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on November 17, 2022. Regulation: 8.
